rs116440799
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BA1BS2
This summary comes from the ClinGen Evidence Repository: The allele frequency of the c.61G>T variant in the ETHE1 gene is 0.7% in gnomAD, including 33 homozygotes which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen ETHE1 Variant Curation Expert Panel (>0.1% in gnomAD- BA1 and BS2). In summary, this variant meets criteria to be classified as benign for ETHE1-related ethylmalonic encephalopathy. ETHE1 specific ACMG/AMP criteria applied: (BA1, BS2). This was reviewed with the ETHE1 expert panel on 2/23/2021 and approved on 2/23/2021. LINK:https://erepo.genome.network/evrepo/ui/classification/CA290780/MONDO:0011229/014
Frequency
Consequence
NM_014297.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ETHE1 | NM_014297.5 | c.61G>T | p.Ala21Ser | missense_variant | Exon 1 of 7 | ENST00000292147.7 | NP_055112.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0185 AC: 2815AN: 152234Hom.: 70 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00478 AC: 741AN: 155116 AF XY: 0.00394 show subpopulations
GnomAD4 exome AF: 0.00233 AC: 3272AN: 1404570Hom.: 79 Cov.: 32 AF XY: 0.00213 AC XY: 1478AN XY: 694728 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0185 AC: 2816AN: 152350Hom.: 70 Cov.: 32 AF XY: 0.0177 AC XY: 1322AN XY: 74498 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Ethylmalonic encephalopathy Benign:5
- -
- -
- -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
The allele frequency of the c.61G>T variant in the ETHE1 gene is 0.7% in gnomAD, including 33 homozygotes which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen ETHE1 Variant Curation Expert Panel (>0.1% in gnomAD- BA1 and BS2). In summary, this variant meets criteria to be classified as benign for ETHE1-related ethylmalonic encephalopathy. ETHE1 specific ACMG/AMP criteria applied: (BA1, BS2). -
not provided Benign:3
- -
- -
- -
not specified Benign:1
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at